Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1963 1
1970 1
1972 1
1974 1
1975 3
1977 2
1978 2
1979 3
1980 4
1981 3
1982 1
1983 3
1984 2
1985 3
1986 4
1987 8
1988 6
1989 8
1990 6
1991 6
1992 4
1993 8
1994 8
1995 8
1996 5
1997 11
1998 10
1999 6
2000 15
2001 13
2002 11
2003 19
2004 21
2005 21
2006 11
2007 8
2008 4
2009 6
2010 7
2011 10
2012 11
2013 11
2014 13
2015 15
2016 13
2017 14
2018 15
2019 16
2020 17
2021 22
2022 23
2023 16
2024 20
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

447 results

Results by year

Filters applied: . Clear all
Page 1
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T; SUSTAIN-6 Investigators. Marso SP, et al. N Engl J Med. 2016 Nov 10;375(19):1834-1844. doi: 10.1056/NEJMoa1607141. Epub 2016 Sep 15. N Engl J Med. 2016. PMID: 27633186 Free article. Clinical Trial.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Bibliometrics.
Klimo P Jr, Michael LM 2nd, Venable GT, Taylor DR. Klimo P Jr, et al. Among authors: michael lm 2nd. J Neurosurg. 2016 Mar;124(3):877-8. doi: 10.3171/2015.7.JNS151647. Epub 2016 Jan 1. J Neurosurg. 2016. PMID: 26722863 No abstract available.
Lepodisiran - A Long-Duration Small Interfering RNA Targeting Lipoprotein(a).
Nissen SE, Ni W, Shen X, Wang Q, Navar AM, Nicholls SJ, Wolski K, Michael L, Haupt A, Krege JH; ALPACA Trial Investigators. Nissen SE, et al. Among authors: michael l. N Engl J Med. 2025 May 1;392(17):1673-1683. doi: 10.1056/NEJMoa2415818. Epub 2025 Mar 30. N Engl J Med. 2025. PMID: 40162643 Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Discovery of potent small-molecule inhibitors of lipoprotein(a) formation.
Diaz N, Perez C, Escribano AM, Sanz G, Priego J, Lafuente C, Barberis M, Calle L, Espinosa JF, Priest BT, Zhang HY, Nosie AK, Haas JV, Cannady E, Borel A, Schultze AE, Sauder JM, Hendle J, Weichert K, Nicholls SJ, Michael LF. Diaz N, et al. Among authors: michael lf. Nature. 2024 May;629(8013):945-950. doi: 10.1038/s41586-024-07387-z. Epub 2024 May 8. Nature. 2024. PMID: 38720069 Free PMC article.
Response.
Taylor DR, Michael LM 2nd, Klimo P Jr. Taylor DR, et al. Among authors: michael lm 2nd. J Neurosurg. 2015 Sep;123(3):544-5. J Neurosurg. 2015. PMID: 26561674 No abstract available.
447 results